SPRITZENVORRICHTUNGEN

European patent · EP3341056 · In force

Register entry

Publication number
EP3341056
Application number
EP16713695
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 17, 2016
Published
Jul 4, 2018
Granted
Jun 15, 2022
Protection ends at the latest
Mar 16, 2036
Next annual fee due
Mar 31, 2027
IPC classes
A61M 5/315 (2006.01)
A61M 5/32 (2006.01)
A61M 5/31 (2006.01)
Priority
US 201562209272 P 24.08.2015
US 201562235984 P 01.10.2015
PCT application
PCT/US2016/022956 17.03.2016
PCT publication
WO2017/034618 02.03.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. May 14, 2024

    Address changed

    Owner
    Adamis Pharmaceuticals Corporation, 11682 El Camino Real, Suite 300, San Diego, CA 92130, USA → DMK Pharmaceuticals Corporation, 11682 El Camino Real, Suite 300, San Diego, CA 92130, USA

    Published in Swissreg on 14.05.2024

  4. Apr 2, 2024

    Change

    Published in Swissreg on 02.04.2024

  5. Jun 9, 2023

    Change

    Published in Swissreg on 09.06.2023

  6. Apr 26, 2023

    Change

    Published in Swissreg on 26.04.2023

  7. Sep 8, 2022

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 08.09.2022

  8. Jun 15, 2022

    Granted

    Published in Swissreg on 15.06.2022

Parties

Inventor

FLATHER, Mark, J.

San Diego, CA 92130, US

MOLL, Thomas

San Diego, CA 92130, US

ROLFS, Bryan, E.

St. Paul, MN 55133-3427, US

DANIELS, Karen, K.

San Diego, CA 92130, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.